Skip to main content

Travoprost Ophthalmic Solution

Type of Posting: Notice of Intent to Revise

Posting Date: 25–Feb–2011

Official Date: Revision Bulletin, Date To Be Determined

Expert Committee: Monographs—Small Molecules 3

In accordance with section 7.05(c) of the 2010–2015 Rules and Procedures of the Council of Experts, this is to provide notice that the USP Monographs—Small Molecules 3 Expert Committee intends to revise the Travoprost Ophthalmic Solution monograph to widen the limit of 15-keto derivative under Organic Impurities, Procedure 2: Limit of Degradation Products in accordance with ICH Q3B guideline and to accommodate other formulation(s).

It is anticipated that the proposed revision will be published as a Revision Bulletin at a date yet to be determined, pursuant to section 7.02 of the Rules and Procedures.

Should you have questions, please contact Feiwen Mao, Scientific Liaison to the Monographs—Small Molecules 3 Expert Committee (301-816-8320 or